Prognostic factors affecting the OS of patients with ATLL
| Characteristics . | Univariate analysis . | Multivariate analysis 1* . | Multivariate analysis 2† . | |||
|---|---|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
| nPD-L1, positive (vs nPD-L1 negative) | 2.455 (1.144-4.642) | .0234 | 2.373 (1.084-4.625) | .0322 | ||
| miPD-L1, positive (vs PD-L1 negative) | 0.525 (0.341-0.811) | .0039 | 0.48 1(0.309-0.750) | .0014 | ||
| JCOG-PI, high (vs low) | 1.777 (1.149-2.710) | .0103 | 1.750 (1.114-2.721) | .0157 | 1.797 (1.112-2.863) | .0172 |
| Age, >70 (vs ≤70) | 1.647 (1.060-2.515) | .0269 | 1.694 (1.080-2.612) | .0224 | 1.656 (1.027-2.615) | .0389 |
| Ann Arbor stage, III/IV (vs I/II) | 1.776 (0.988-3.530) | .0551 | 1.640 (0.903-3.283) | .1081 | 1.829 (0.999-3.687) | .0503 |
| LDH, elevated (vs normal) | 1.000 (0.664-1.513) | .9986 | 0.850 (0.554-1.309) | .4575 | 0.945 (0.599-1.671) | .8089 |
| Characteristics . | Univariate analysis . | Multivariate analysis 1* . | Multivariate analysis 2† . | |||
|---|---|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | |
| nPD-L1, positive (vs nPD-L1 negative) | 2.455 (1.144-4.642) | .0234 | 2.373 (1.084-4.625) | .0322 | ||
| miPD-L1, positive (vs PD-L1 negative) | 0.525 (0.341-0.811) | .0039 | 0.48 1(0.309-0.750) | .0014 | ||
| JCOG-PI, high (vs low) | 1.777 (1.149-2.710) | .0103 | 1.750 (1.114-2.721) | .0157 | 1.797 (1.112-2.863) | .0172 |
| Age, >70 (vs ≤70) | 1.647 (1.060-2.515) | .0269 | 1.694 (1.080-2.612) | .0224 | 1.656 (1.027-2.615) | .0389 |
| Ann Arbor stage, III/IV (vs I/II) | 1.776 (0.988-3.530) | .0551 | 1.640 (0.903-3.283) | .1081 | 1.829 (0.999-3.687) | .0503 |
| LDH, elevated (vs normal) | 1.000 (0.664-1.513) | .9986 | 0.850 (0.554-1.309) | .4575 | 0.945 (0.599-1.671) | .8089 |